Institutional Ownership Trevi Therapeutics, Inc. (TRVI)
This table provides information about the institutional ownership of Trevi Therapeutics, Inc. (TRVI). We have compiled data on the 163 institutions that hold shares in the stock, with a total of 109 Million shares, which have been reported (via 13F filing form) to have a value of $847 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
1,097,497
shares
|
$8.49 Million
0.0% of portfolio
|
Q2 2025
Added 732.92%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Aug 14, 2025 Q2 2025 |
1,076,683
shares
|
$8.33 Million
0.0% of portfolio
|
Q2 2025
Added 111.37%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
1,024,011
shares
|
$7.93 Million
0.0% of portfolio
|
Q2 2025
Added 107.05%
|
|
|
J. Goldman & CO LP
New York, NY |
Aug 14, 2025 Q2 2025 |
979,098
shares
|
$7.58 Million
0.14% of portfolio
|
Q2 2025
Added 386.85%
|
|
|
Logos Global Management LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
850,000
shares
|
$6.58 Million
0.6% of portfolio
|
Q2 2025
Added 100.13%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
824,180
shares
|
$6.38 Million
0.0% of portfolio
|
Q2 2025
Added 4215.53%
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Aug 14, 2025 Q2 2025 |
799,957
shares
|
$6.19 Million
1.2% of portfolio
|
Q2 2025
New holding
|
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
700,000
shares
|
$5.42 Million
0.3% of portfolio
|
Q2 2025
New holding
|
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
Aug 14, 2025 Q2 2025 |
650,000
shares
|
$5.03 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
576,471
shares
|
$4.46 Million
0.0% of portfolio
|
Q2 2025
Added 1.81%
|
|
|
Panagora Asset Management Inc
Boston, MA |
Aug 13, 2025 Q2 2025 |
569,702
shares
|
$4.41 Million
0.01% of portfolio
|
Q2 2025
Added 67.61%
|
|
|
Silverarc Capital Management, LLC
|
Aug 14, 2025 Q2 2025 |
539,587
shares
|
$4.18 Million
0.71% of portfolio
|
Q2 2025
Added 1.81%
|
|
|
Burkehill Global Management, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
525,000
shares
|
$4.06 Million
0.21% of portfolio
|
Q2 2025
New holding
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
515,476
shares
|
$3.99 Million
0.0% of portfolio
|
Q2 2025
Added 273.72%
|
|
|
Acuta Capital Partners, LLC
Belmont, CA |
Aug 14, 2025 Q2 2025 |
493,735
shares
|
$3.82 Million
6.71% of portfolio
|
Q2 2025
Reduced 37.18%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
489,300
shares
|
$3.79 Million
0.0% of portfolio
|
Q2 2025
Added 450.39%
|
|
|
Eam Investors, LLC
Solana Beach, CA |
Aug 12, 2025 Q2 2025 |
486,624
shares
|
$3.77 Million
0.49% of portfolio
|
Q2 2025
Reduced 11.67%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
447,852
shares
|
$3.47 Million
0.0% of portfolio
|
Q2 2025
Added 254.79%
|
|
|
Opaleye Management Inc.
Boston, MA |
Aug 15, 2025 Q2 2025 |
390,000
shares
|
$3.02 Million
0.51% of portfolio
|
Q2 2025
Reduced 50.94%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
354,225
shares
|
$2.74 Million
0.0% of portfolio
|
Q2 2025
Added 280.75%
|
|
|
Tejara Capital LTD
London, X0 |
Aug 13, 2025 Q2 2025 |
326,395
shares
|
$2.53 Million
0.83% of portfolio
|
Q2 2025
Added 81.82%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
322,339
shares
|
$2.49 Million
0.0% of portfolio
|
Q2 2025
Reduced 62.21%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
299,045
shares
|
$2.31 Million
0.0% of portfolio
|
Q2 2025
Added 41.14%
|
|
|
Prudential Financial Inc
Newark, NJ |
Aug 12, 2025 Q2 2025 |
226,381
shares
|
$1.75 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
225,935
shares
|
$1.75 Million
0.0% of portfolio
|
Q2 2025
Added 8.87%
|